Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
25.14
0.2 (0.8%)
BSENSE

Nov 20

BSE+NSE Vol: 52.72 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

52.72 lacs (65.52%) Volume

Shareholding (Sep 2026)

FII

1.00%

Held by 5 FIIs

DII

0.30%

Held by 2 DIIs

Promoter

52.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a growth in Net Sales of 15.8%, the company declared Very Positive results in Sep 26

  • NET SALES(Q) Highest at Rs 105.61 cr
  • PBDIT(Q) Highest at Rs 25.24 cr.
  • PBT LESS OI(Q) Highest at Rs 23.42 cr.
2

Stock is technically in a Mildly Bullish range

3

With ROE of 13.2, it has a Very Expensive valuation with a 6.4 Price to Book Value

4

Falling Participation by Institutional Investors

5

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 1,295 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.20

stock-summary
Return on Equity

13.25%

stock-summary
Price to Book

6.28

Revenue and Profits:
Net Sales:
106 Cr
(Quarterly Results - Sep 2026)
Net Profit:
13 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
75.07%
0%
75.07%
6 Months
88.88%
0%
88.88%
1 Year
63.04%
0%
63.04%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

19-Nov-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

06-Nov-2026 | Source : BSE

We have attached herewith earning call transcript for the H1/Q2 FY-27.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

03-Nov-2026 | Source : BSE

We have attached herewith link of Investor Call recording held on Tuesday November 03 2026.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

stock-summary
BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
46.70%
EBIT Growth (5y)
47.11%
EBIT to Interest (avg)
10.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.86
Tax Ratio
34.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.30%
ROCE (avg)
9.07%
ROE (avg)
19.87%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
40
Price to Book Value
6.40
EV to EBIT
29.85
EV to EBITDA
28.77
EV to Capital Employed
5.49
EV to Sales
7.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.41%
ROE (Latest)
13.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 5 FIIs (1.0%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

29.24%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 95.13% vs -44.10% in Jun 2026",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 67.71% vs -50.97% in Jun 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'26",
        "Jun'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60.45",
          "val2": "30.98",
          "chgp": "95.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.47",
          "val2": "7.47",
          "chgp": "93.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.94",
          "val2": "0.96",
          "chgp": "-2.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.05",
          "val2": "4.80",
          "chgp": "67.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.94%",
          "val2": "24.11%",
          "chgp": "-0.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Anlon Healthcare"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Anlon Healthcare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQstock-summary
Sep'26
Jun'26
Change(%)
Net Sales
60.45
30.98
95.13%
Operating Profit (PBDIT) excl Other Income
14.47
7.47
93.71%
Interest
0.94
0.96
-2.08%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.05
4.80
67.71%
Operating Profit Margin (Excl OI)
23.94%
24.11%
-0.17%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2026 is 95.13% vs -44.10% in Jun 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 67.71% vs -50.97% in Jun 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
176.50
120.29
46.73%
Operating Profit (PBDIT) excl Other Income
46.14
32.21
43.25%
Interest
4.35
3.72
16.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
27.81
20.52
35.53%
Operating Profit Margin (Excl OI)
26.14%
26.78%
-0.64%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details